paclitaxel has been researched along with Astrocytosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, A; Boitano, S; DeFea, KA; Dussor, G; Kume, M; Price, TJ; Vagner, J | 1 |
de Bruin, N; Geisslinger, G; Hahnefeld, L; Hausch, F; Heymann, T; Namendorf, C; Schmidt, MV; Schreiber, Y; Sisignano, M; Thomas, D; Uhr, M; Wedel, S | 1 |
Anmin, J; Bo, Y; Hui, Z; Shaoxiong, M; Yinhai, C; Zhilai, Z | 1 |
Dosch, HM; Fish, EN; Galligan, C; Mastronardi, FG; Moscarello, MA; Selvanantham, T; Tsui, H; Winer, S; Wood, DD | 1 |
Ludwin, SK; Mak, B; Mastronardi, F; Moscarello, MA; Nguyen, TA; Wood, DD | 1 |
5 other study(ies) available for paclitaxel and Astrocytosis
Article | Year |
---|---|
Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Topics: Animals; Female; Ganglia, Spinal; Gliosis; Hyperalgesia; Male; Mice; Mice, Knockout; Paclitaxel; Pain; Peripheral Nervous System Diseases; Receptor, PAR-2; Sensory Receptor Cells | 2023 |
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators.
Topics: Animals; Gliosis; Lipids; Mice; Neuralgia; Neuroinflammatory Diseases; Paclitaxel | 2023 |
A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Axons; Cell Movement; Cell Survival; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Female; Gliosis; Humans; Macrophages; Mesenchymal Stem Cell Transplantation; Microglia; Motor Activity; Paclitaxel; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Injuries; Transplantation, Heterologous | 2012 |
Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autoimmune Diseases; Demyelinating Diseases; Drug Synergism; Gliosis; Methylation; Mice; Mice, Inbred Strains; Mice, Transgenic; Myelin Basic Protein; Nerve Fibers, Myelinated; Nerve Regeneration; Paclitaxel; STAT1 Transcription Factor; T-Lymphocytes; Vitamin B 12; Vitamin B Complex | 2007 |
Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination.
Topics: Animals; Astrocytes; Biomarkers; Brain; Cell Division; Cell Nucleus; Cerebellum; Drug Evaluation, Preclinical; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Gliosis; Hereditary Central Nervous System Demyelinating Diseases; Injections, Intraperitoneal; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Multiple Sclerosis; Myelin Proteins; Myelin Proteolipid Protein; Myelin Sheath; Nerve Tissue Proteins; Nervous System Autoimmune Disease, Experimental; Oligodendroglia; Paclitaxel; Signal Transduction | 2002 |